|
||||||||||||||||||
|
||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq. DescriptionThe MAb1 antibody reacts with human tumor necrosis factor-alpha (TNF-α), a 17 kDa cytokine produced by monocytes, macrophages, neutrophils, NK cells and CD4+ T cells. TNF-α has cytolytic activity against a range of tumor cells and is important in immune regulation. TNF-α forms dimers and trimers and also exists as a 26 kDa membrane bound form. Applications ReportedFor research use only, not for diagnostic or therapeutic use. The Mab1 antibody has been reported for use in ELISA, ELISPOT, intracellular staining and neutralization. Applications TestedThe MAb1 antibody has been tested for neutralizing TNF-α binding and biological activity. References
Danis, V. A., G. M. Franic, et al. (1991). "Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-2, interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and IL-6 on the production of immunoreactive IL-1 and TNF-alpha by human monocytes." Clin Exp Immunol 85(1): 143-50. Rathjen, D. A., K. Cowan, et al. (1991). "Antigenic structure of human tumour necrosis factor: recognition of distinct regions of TNF alpha by different tumour cell receptors." Mol Immunol 28(1-2): 79-86. Related ProductsCat. 16-4714 Functional Grade Purified Mouse IgG1, K Isotype Control Cat. 13-7349 Biotin anti-human TNFa (Tumor Necrosis Factor alpha, TNF-alpha, TNF-a) (clone MAb11) Cat. 14-8329 Recombinant Human TNFa (Tumor Necrosis Factor alpha, TNF-alpha, TNF-a) |
|||||||||||||||||||||||||||||||||||||||||||||
![]() |
![]() |
|
Copyright © 2000-2008 eBioscience, Inc. Product For Research Use Only: Not for further distribution without written consent. |